BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2523657)

  • 1. Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling.
    Moore KH; Clemmer JS
    Am J Physiol Renal Physiol; 2021 Oct; 321(4):F548-F557. PubMed ID: 34486399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute haemodynamic effects of isradipine in hypertensive heart transplant recipients.
    Aass H; Simonsen S
    Eur J Clin Pharmacol; 1993; 45(2):187-9. PubMed ID: 8223843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.
    Leppert J; Nilsson H; Myrdal U; Edvinsson L; Hedner T; Ringqvist I
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):901-7. PubMed ID: 8011569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do calcium channel blockers have renal protective effects?
    Reams GP
    Drugs Aging; 1994 Oct; 5(4):263-87. PubMed ID: 7827397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.
    Brogden RN; Sorkin EM
    Drugs; 1995 Apr; 49(4):618-49. PubMed ID: 7789292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
    Grimm RH; Flack JM; Byington R; Bond G; Brugger S
    Drugs; 1990; 40 Suppl 2():38-43. PubMed ID: 2150640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isradipine in Asian patients with hypertension.
    Zubair M; Karim S; Hussain S
    Drugs; 1990; 40 Suppl 2():26-9. PubMed ID: 2150636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isradipine in hypertension.
    Hansson L
    Drugs; 1990; 40 Suppl 2():10-4. PubMed ID: 2150633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of the new calcium channel blocking drug isradipine.
    Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
    Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.
    Fitton A; Benfield P
    Drugs; 1990 Jul; 40(1):31-74. PubMed ID: 2143980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antihypertensive therapy on renal function.
    Frei U; Schindler R; Koch KM
    Clin Investig; 1992; 70 Suppl 1():S120-6. PubMed ID: 1591504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
    Persson B; Wysocki M; Andersson OK
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
    Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
    Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
    Dahlöf B
    Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel entry blocker therapy for hypertensive patients with concomitant renal impairment: a focus on isradipine.
    Frishman WH
    J Clin Pharmacol; 1994 Dec; 34(12):1164-72. PubMed ID: 7738211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and hemodynamic effects of isradipine in essential hypertension.
    Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M
    Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoconstriction during acute hypervolemic hemodilution in hypertensive patients is not prevented by calcium blockade.
    Wysocki M; Andersson OK; Persson B; Bagge U
    Angiology; 1998 Jan; 49(1):41-8. PubMed ID: 9456163
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.